ARTLW
Closed
Artelo Biosciences Inc
0.0056
+0.0005 (+9.80%)
Last Update: 17 Jun 2024 23:00:00
Yesterday: 0.0051
Day's Range: 0.0052 - 0.006
Send
sign up or login to leave a comment!
When Written:
0.0698
Artelo Biosciences Inc is a biopharmaceutical company that focuses on developing and commercializing drugs to treat cancer and other diseases. The company is headquartered in La Jolla, California, and was founded in 2011.
Artelo's lead product candidate is ART27.13, a synthetic cannabinoid that is being developed for the treatment of cancer-related anorexia and weight loss. The company is also developing other cannabinoid-based therapies for the treatment of pain and inflammation.
In addition to its drug development programs, Artelo has a research collaboration with the University of Nottingham in the UK to develop new cannabinoid-based therapies for the treatment of cancer.
The company is publicly traded on the NASDAQ exchange under the ticker symbol "ARTL".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Artelo's lead product candidate is ART27.13, a synthetic cannabinoid that is being developed for the treatment of cancer-related anorexia and weight loss. The company is also developing other cannabinoid-based therapies for the treatment of pain and inflammation.
In addition to its drug development programs, Artelo has a research collaboration with the University of Nottingham in the UK to develop new cannabinoid-based therapies for the treatment of cancer.
The company is publicly traded on the NASDAQ exchange under the ticker symbol "ARTL".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








